*Correspondence: Kai Liang, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A new range of drugs, currently in the research phase, aim to solve bottlenecks from the original wave
Once it's opened, contamination risk goes up with every use after that, so it should be used within 24 hours of opening
in 2020 showed no improvement in the CPR (OR = 1.15, 95% CI = 0.95 140) or LBR (0.94, 95% CI = 0.41- 2.15) when AOXs were given to women treated with IVF or ICSI (188)
Bepranemab, a monoclonal antibody against the microtubule-binding region, showed biomarker improvement in a Phase 2 study that ended in 2024, but people enrolled in the trial had no change in cognition
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections